ZNF740 and acute myeloid leukemia: Moreover, the correlation between ZNF740 expression level and venetoclax therapeutic response was not limited to monocytic differentiation AML but also extended to other FAB subtypes (Supplementary Fig. 1C, D), suggesting a broader role for ZNF740 in venetoclax resistance in AML.